Literature DB >> 23362846

Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.

Radwa O Abbas1, Hassan M E Azzazy.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) is one of the leading causes of blindness in the elderly worldwide. Several single nucleotide polymorphisms (SNPs) have been linked to the risk of developing AMD. We aimed to examine the association between AMD and SNPs on CFH, ARMS2 and HTRA1 in Egyptians, a previously unstudied population.
MATERIALS AND METHODS: Genomic DNA was extracted from 26 AMD patients and 20 controls. Genotyping was performed using PCR followed by allele-specific restriction digestion and direct sequencing.
RESULTS: CFH rs1061170 was significantly associated with AMD with the frequency of the risk C allele being 0.53 in patients and 0.17 in controls (p < 0.017). The odds ratio (OR) for the TC genotype was 5.5 (95% CI: 1.1-26.4) and for combined TC + CC genotypes was 8 (95% CI: 1.7-37.1). ARMS2 rs10490924 was also significantly associated with the risk allele T found at a frequency of 0.5 in AMD and 0.15 in controls (p < 0.017, χ(2) test). The OR for the TG genotype was 4.667 (95% CI: 1.2-18.4) and for combined TG + TT genotypes was 7 (95% CI: 1.8-26.5). HTRA1 rs11200638 also was significantly associated, with the risk allele A found at a frequency of 0.44 in patients and 0.17 in controls (p < 0.017, χ(2) test). OR for GA genotype was 5 (95% CI: 1.2-20.9) and for the combined GA + AA genotypes was 6 (95% CI: 1.4-24.7).
CONCLUSIONS: Our data demonstrates significant association between AMD and rs1061170 on CFH, rs10490924 on ARMS2 and rs11200638 on HTRA1 in Egyptian patients. These findings are in agreement with previous findings in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23362846     DOI: 10.3109/13816810.2012.762934

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian population.

Authors:  Mohammad Askari; Amin Reza Nikpoor; Fazel Gorjipour; Mohsen Mazidi; Mohammad Hosein Sanati; Hajar Aryan; Alireza Irani; Khalil Ghasemi Falavarjani; Hossein Nazari; Kazem Mousavizadeh
Journal:  Rep Biochem Mol Biol       Date:  2015-10

2.  Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.

Authors:  Seigo Yoneyama; Yoichi Sakurada; Fumihiko Mabuchi; Mitsuhiro Imasawa; Atsushi Sugiyama; Takeo Kubota; Hiroyuki Iijima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-05       Impact factor: 3.117

3.  Association of HTRA1 and CFH gene polymorphisms with age-related macular degeneration in Ningbo, China.

Authors:  Yan Gong; Yu Zhan; Tao Yuan; Yanhong Liao; Lingyi Zhang; Xiaotian Liu; Yuanhao Zheng; Yongbo Bao
Journal:  Int Ophthalmol       Date:  2021-01-02       Impact factor: 2.031

4.  A Pilot Application of an iTRAQ-Based Proteomics Screen Estimates the Effects of Cigarette Smokers' Serum on RPE Cells With AMD High-Risk Alleles.

Authors:  Bincui Cai; Zhe Zhang; Shuo Sun; Tingting Lin; Yifeng Ke; Zhiqing Li; Jin Yang; Xiaorong Li
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

5.  Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration.

Authors:  Nilsa La Cunza; Li Xuan Tan; Thushara Thamban; Colin J Germer; Gurugirijha Rathnasamy; Kimberly A Toops; Aparna Lakkaraju
Journal:  JCI Insight       Date:  2021-05-10

6.  Association of the HtrA1 rs11200638 Polymorphism with Neovascular Age-Related Macular Degeneration in Indonesia.

Authors:  Supanji Supanji; Ayudha Bahana Ilham Perdamaian; Dewi Fathin Romdhoniyyah; Muhammad Bayu Sasongko; Angela Nurini Agni; Firman Setya Wardhana; Tri Wahyu Widayanti; Muhammad Eko Prayogo; Chio Oka; Masashi Kawaichi
Journal:  Ophthalmol Ther       Date:  2021-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.